[Chronic refractory anemia with hyperplastic bone marrow].
D000748:Anemia, Macrocytic / Q000150:complications; D000756:Anemia, Sideroblastic / Q000097:blood / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D001772:Blood Cell Count; D001855:Bone Marrow Diseases / Q000150:complications*; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D006432:Hemochromatosis / Q000209:etiology; D006801:Humans; D006965:Hyperplasia; D007501:Iron / Q000097:blood / Q000378:metabolism; D004915:Leukemia, Erythroblastic, Acute / Q000097:blood / Q000150:complications* / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009192:Myelography; D011230:Precancerous Conditions; D011379:Prognosis; D011736:Pyridoxine / Q000627:therapeutic use
D005492:Folic Acid; D007501:Iron; D011736:Pyridoxine
Chronische refraktäre Anämien mit hyperplastischem Knochenmark.